University of Michigan Comprehensive Cancer CenterDivision of Hematology/Oncology

Ann Arbor, Michigan 48109

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Multiple Myeloma Clinical Trial
A Study to Determine Dose and Tolerability of CC-220 Monotherapy, in Combination With Dexamethasone, and in Combination With Dexamethasone and Daratumumab or Bortezomib in Subjects With Relapsed and Refractory Multiple Myeloma (MM)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Michigan Comprehensive Cancer CenterDivision of Hematology/Oncology
mi
from
Ann Arbor, MI
Click here to add this to my saved trials